TipRanks
Go Ultimate55% OFF

STRATEC Biomedical (SBS) Stock Forecast & Price Target

6 Followers
See the Price Targets and Ratings of:

SBS Analyst Ratings

Moderate Buy
2Ratings
1Buy1Hold0Sell
Based on 2 analysts giving stock ratings to STRATEC Biomedical in the past 3 months

SBS Stock 12 Month Forecast

EUR 30.00▲(17.42% Upside)
Based on 2 Wall Street analysts offering 12 month price targets for STRATEC Biomedical in the last 3 months. The average price target is EUR 30.00 with a high forecast of EUR 39.00 and a low forecast of EUR 21.00. The average price target represents a 17.42% change from the last price of EUR 25.55.
Highest Price TargetEUR 39.00Average Price TargetEUR 30.00Lowest Price TargetEUR 21.00

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for DE:SBS
Price TargetFollowArticle
Berenberg BankEUR 37→EUR 39buy52.64%UpsideReiterated11/03/26
Deutsche Bank EUR 21hold-17.81%DownsideReiterated11/03/26
Kepler Capital EUR 26buy1.76%UpsideReiterated05/26/26
Stocks with the Highest Top Analyst Consensus in the General Sector
STDNStandard Nuclear
SKHYSK Hynix
ITGITG Inc. Class A
LIMENeutron Holdings, Inc.
EROCERock

Find stocks in the General sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering STRATEC Biomedical

3 Months
Michael Heider
Michael HeiderBerenberg Bank
Success Rate9/22 ratings generated profit
41%
Average Return
-0.78%

Copying Michael Heider's trades and holding each position for 3 Months would result in 40.91% of your transactions generating a profit, with an average return of -0.78% per trade.

1 Year
Michael Heider
Michael HeiderBerenberg Bank
Success Rate10/22 ratings generated profit
45%
Average Return
-3.60%

Copying Michael Heider's trades and holding each position for 1 Year would result in 45.45% of your transactions generating a profit, with an average return of -3.60% per trade.

2 Years
Michael Heider
Michael HeiderBerenberg Bank
Success Rate11/22 ratings generated profit
50%
Average Return
-0.22%

Copying Michael Heider's trades and holding each position for 2 Years would result in 50.00% of your transactions generating a profit, with an average return of -0.22% per trade.

SBS Analyst Recommendation Trends

02468Nov 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26
Monthly rating counts for SBS
RatingJun 26Jul 26Aug 26Sep 26Oct 26
Strong Buy32222
Buy00000
Hold32211
Sell00000
Strong Sell00000
total64433

In the current month, SBS has received 2 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. SBS average Analyst price target in the past 3 months is 30.00.

SBS Financial Forecast

EUR -2EUR -1.25EUR -0.5EUR 0.25EUR 1Q3 2025Q2 2026Q3 2026
HighEUR 0.15
ConsensusEUR 0.15
LowEUR 0.15

SBS Earnings Forecast

Next quarter’s earnings estimate for SBS is EUR 0.15 with a range of EUR 0.15 to EUR 0.15. The previous quarter’s EPS was EUR 0.39. Its overall industry beat the EPS estimate 50.49% of the time in the past 12 months.

EUR 53.4MEUR 69.7MEUR 86MEUR 102.3MEUR 118.6MQ3 2025Q2 2026Q3 2026
HighEUR 59M
ConsensusEUR 58.5M
LowEUR 58M

SBS Sales Forecast

Next quarter’s sales forecast for SBS is EUR 58.50M with a range of EUR 58.00M to EUR 59.00M. The previous quarter’s sales results were EUR 59.11M. Its overall industry beat sales estimates 63.25% of the time in the past 12 months.

SBS Stock Forecast FAQ

What is DE:SBS’s average 12-month price target, according to analysts?
Based on analyst ratings, STRATEC Biomedical’s 12-month average price target is €30.00.
What is DE:SBS’s upside potential, based on the analysts’ average price target?
STRATEC Biomedical has 17.42% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is STRATEC Biomedical a Buy, Sell or Hold?
STRATEC Biomedical has a consensus rating of Moderate Buy, which is based on 1 buy ratings, 1 hold ratings and 0 sell ratings.
What is STRATEC Biomedical’s share price target?
The average share price target for STRATEC Biomedical is €30.00. This is based on 2 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is €39.00, and the lowest forecast is €21.00. The average share price target represents a 17.42% increase from the current price of €25.55.
What do analysts say about STRATEC Biomedical?
STRATEC Biomedical’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 2 Wall Street analysts.
How can I buy shares of STRATEC Biomedical?
To buy shares of DE:SBS, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.